COUR PHARMACEUTICALS DEV COMPANY has a total of 24 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, environmental technology and measurement are COMBINATORX INC, ZHUHAI QIWEI BIOTECHNOLOGY CO LTD and KARAOLIS DAVID K R.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Israel | 2 | |
#5 | Japan | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Brazil | 1 | |
#10 | Canada | 1 | |
#11 | China | 1 | |
#12 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Measurement | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Getts Daniel | 14 |
#2 | King Nicholas | 13 |
#3 | Terry Rachael | 5 |
#4 | Daniel Getts | 5 |
#5 | Nicholas King | 5 |
#6 | Getts Daniel R | 3 |
#7 | Rachael Terry | 1 |
#8 | N Jin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016057909A1 | Immune-modifying particles for the treatment of ebola virus | |
CA2903718A1 | Immune-modifying particles for the treatment of inflammation | |
AU2011325966A1 | Modified immune-modulating particles |